Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Baclofen
Drug ID BADD_D00209
Description Baclofen is a gamma-aminobutyric acid (GABA) agonist used as a skeletal muscle relaxant used for the relief of painful and uncomfortable muscle spasms caused by a variety of conditions. It is particularly useful in treating muscle spasticity associated with spinal cord injury. This drug has recently been studied for the management of alcohol withdrawal, however, a conclusion has not been made regarding baclofen efficacy in this condition. [A173908,A173911,A173938] This drug was first approved by the FDA in 1992.[F4570]
Indications and Usage For the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Marketing Status Prescription; Discontinued
ATC Code M03BX01
DrugBank ID DB00181
KEGG ID D00241
MeSH ID D001418
PubChem ID 2284
TTD Drug ID D01AJY
NDC Product Code 0527-1333; 80425-0112; 67457-563; 70771-1449; 72888-011; 52817-321; 68071-2414; 68071-4905; 55700-408; 60687-514; 45865-355; 70518-0362; 68788-7915; 50090-5855; 63629-6883; 61919-095; 68071-5252; 80425-0157; 68981-007; 70518-2662; 70511-121; 51927-0146; 0527-1330; 48954-469; 70511-124; 76420-931; 55700-403; 50090-1801; 70710-1609; 67457-564; 52817-319; 46014-1124; 71610-444; 70518-2173; 68055-946; 63629-1228; 70756-085; 50090-4682; 71335-0949; 50268-107; 72888-009; 51927-0147; 12658-0584; 63629-2128; 12658-0583; 0115-1011; 63629-2081; 10135-533; 60687-503; 68788-9246; 68084-868; 59651-394; 63629-3193; 65015-635; 67457-562; 53747-075; 65628-100; 71335-1797; 25021-680; 68134-401; 0615-3542; 70710-1286; 63275-9992; 63629-2131; 76420-930; 70771-1586; 55154-7635; 12658-0582; 0832-1054; 17511-130; 73320-001; 70257-562; 70257-414; 72888-010; 25021-681; 81371-6004; 50090-0564; 63629-2129; 61919-093; 71930-066; 43063-865; 31722-138; 50090-1650; 63629-2080; 16714-072; 70518-3089; 0615-8411; 59651-395; 68788-6384; 71610-614; 31722-999; 80425-0156; 50436-9022; 0615-8412; 46014-1035; 38779-3209; 71610-452; 50268-106; 29300-344; 71335-0103; 55289-757; 73320-003; 10135-532; 51552-0613; 71610-446; 71335-1356; 70518-3115; 70511-122; 70710-1285; 71930-006; 70756-289; 63629-1225; 65628-101; 0904-6475; 79572-003; 16714-071; 71525-010; 70518-2804; 70511-123; 63629-1226; 71610-391; 63629-2130; 71335-1664; 63187-313; 71335-0206; 68084-855; 63629-2083; 29300-343; 42291-158; 0115-1010; 52652-6001; 73320-002; 50090-5838; 38779-0388; 63629-1227; 71930-007; 68071-2289; 0172-4096; 25021-678; 62991-1013; 17856-0319; 43063-864; 63629-2082; 63187-280; 71335-1643; 50090-2871; 0603-2406; 0527-1337; 12658-0448; 68055-947; 68055-945; 50436-0060; 63629-1224; 68055-948; 70934-918; 63629-6406; 51927-2007; 0615-3541; 70257-416; 50218-010; 68071-3001; 61919-027; 70934-227; 0904-6476; 45865-452; 63187-274; 51014-7035; 52817-320; 55154-7876; 80425-0080; 80425-0081; 0395-8032; 63629-1286; 63739-480; 71525-040; 71525-005; 61919-026; 76420-165; 63739-479; 0115-1012; 70257-412; 67544-671; 31722-998; 0832-1055; 70771-1448; 68071-2420; 50268-105; 70756-288; 68071-3075; 0172-4097; 0603-2407; 50090-2493; 71335-0344; 71205-474; 69528-301; 49452-0807; 68071-5249; 25021-679; 72969-004; 63187-147; 71335-1796; 63629-2084
Synonyms Baclofen | Baclophen | PCP-GABA | beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid | Chlorophenyl GABA | GABA, Chlorophenyl | beta-(p-Chlorophenyl)-gamma-aminobutyric Acid | Clofen | Gen-Baclofen | Gen Baclofen | GenBaclofen | Genpharm | Apo-Baclofen | Apo Baclofen | ApoBaclofen | Atrofen | Baclofène-Irex | Baclofène Irex | BaclofèneIrex | Baclofen AWD | AWD, Baclofen | Lebic | Lioresal | Liorésal | Nu-Baclo | Nu Baclo | NuBaclo | PMS-Baclofen | PMS Baclofen | PMSBaclofen | Baclospas | Ba-34,647 | Ba34,647 | Ba-34647 | Ba34647 | CIBA-34,647-BA | CIBA34,647BA
Chemical Information
Molecular Formula C10H12ClNO2
CAS Registry Number 1134-47-0
SMILES C1=CC(=CC=C1C(CC(=O)O)CN)Cl
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Abdominal tenderness07.01.05.0040.000337%Not Available
Accommodation disorder06.02.04.001--Not Available
Acidosis14.01.03.0020.000505%
Acute myocardial infarction02.02.02.001; 24.04.04.001--Not Available
Acute respiratory distress syndrome22.01.03.0010.000132%
Acute respiratory failure14.01.04.004; 22.02.06.0010.000264%Not Available
Affective disorder19.04.04.0010.000505%Not Available
Ageusia07.14.03.003; 17.02.07.001--Not Available
Aggression19.05.01.001--Not Available
Agitation17.02.05.012; 19.06.02.0010.013133%
Akathisia17.01.02.002; 19.06.02.006--
Alanine aminotransferase increased13.03.01.003--
Albuminuria20.02.01.001--Not Available
Alopecia23.02.02.001--
Altered state of consciousness17.02.04.001; 19.07.01.0030.006903%Not Available
Ammonia increased13.03.01.0230.000337%Not Available
Amnesia17.03.02.001; 19.20.01.0010.003536%
Anaemia01.03.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Ankle fracture12.04.01.005; 15.08.03.0050.000337%
Anuria20.01.03.0020.001347%Not Available
Anxiety19.06.02.002--
Aphasia17.02.03.001; 19.21.01.0010.002862%
Apnoea22.02.01.0010.003704%
Arachnoiditis12.02.04.002; 17.06.01.0010.001010%
Areflexia17.02.01.0010.002862%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 23 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene